Literature DB >> 22454501

Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity.

Jiyoung Kim1, René Villadsen, Therese Sørlie, Louise Fogh, Signe Z Grønlund, Agla J Fridriksdottir, Irene Kuhn, Fritz Rank, Vera Timmermans Wielenga, Hiroko Solvang, Paul A W Edwards, Anne-Lise Børresen-Dale, Lone Rønnov-Jessen, Mina J Bissell, Ole William Petersen.   

Abstract

The majority of human breast cancers exhibit luminal epithelial differentiation. However, most aggressive behavior, including invasion and purported cancer stem cell activity, are considered characteristics of basal-like cells. We asked the following questions: Must luminal-like breast cancer cells become basal-like to initiate tumors or to invade? Could luminally differentiated cells within a basally initiated hierarchy also be tumorigenic? To answer these questions, we used rare and mutually exclusive lineage markers to isolate subsets of luminal-like and basal-like cells from human breast tumors. We enriched for populations with or without prominent basal-like traits from individual tumors or single cell cloning from cell lines and recovered cells with a luminal-like phenotype. Tumor cells with basal-like traits mimicked phenotypic and functional behavior associated with stem cells assessed by gene expression, mammosphere formation and lineage markers. Luminal-like cells without basal-like traits, surprisingly, were fully capable of initiating invasive tumors in NOD SCID gamma (NSG) mice. In fact, these phenotypically pure luminal-like cells generated larger and more invasive tumors than their basal-like counterparts. The tumorigenicity and invasive potential of the luminal-like cancer cells relied strongly on the expression of the gene GCNT1, which encodes a key glycosyltransferase controlling O-glycan branching. These findings demonstrate that basal-like cells, as defined currently, are not a requirement for breast tumor aggressiveness, and that within a single tumor there are multiple "stem-like" cells with tumorigenic potential casting some doubt on the hypothesis of hierarchical or differentiative loss of tumorigenicity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22454501      PMCID: PMC3341000          DOI: 10.1073/pnas.1203203109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties.

Authors:  Thorarinn Gudjonsson; René Villadsen; Helga Lind Nielsen; Lone Rønnov-Jessen; Mina J Bissell; Ole William Petersen
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

2.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.

Authors:  Gabriela Dontu; Wissam M Abdallah; Jessica M Foley; Kyle W Jackson; Michael F Clarke; Mari J Kawamura; Max S Wicha
Journal:  Genes Dev       Date:  2003-05-15       Impact factor: 11.361

3.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

4.  Notch-induced mammary tumorigenesis does not involve the lobule-limited epithelial progenitor.

Authors:  R D Bruno; C A Boulanger; G H Smith
Journal:  Oncogene       Date:  2011-06-13       Impact factor: 9.867

5.  Antigenic subsets of human breast epithelial cells distinguished by monoclonal antibodies.

Authors:  P A Edwards; I M Brooks
Journal:  J Histochem Cytochem       Date:  1984-05       Impact factor: 2.479

6.  The differentiated state of normal and malignant cells or how to define a "normal" cell in culture.

Authors:  M J Bissell
Journal:  Int Rev Cytol       Date:  1981

7.  Determination of subcutaneous tumor size in athymic (nude) mice.

Authors:  M M Tomayko; C P Reynolds
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

8.  Two mouse hybridoma antibodies against human milk-fat globules recognise the I(Ma) antigenic determinant beta-D-Galp-(1 leads to 4)-beta-D-GlcpNAc-(1 leads to 6).

Authors:  H C Gooi; K Uemura; P A Edwards; C S Foster; N Pickering; T Feizi
Journal:  Carbohydr Res       Date:  1983-08-16       Impact factor: 2.104

Review 9.  Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation.

Authors:  G B Pierce; W C Speers
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

10.  Repeated observation of breast tumor subtypes in independent gene expression data sets.

Authors:  Therese Sorlie; Robert Tibshirani; Joel Parker; Trevor Hastie; J S Marron; Andrew Nobel; Shibing Deng; Hilde Johnsen; Robert Pesich; Stephanie Geisler; Janos Demeter; Charles M Perou; Per E Lønning; Patrick O Brown; Anne-Lise Børresen-Dale; David Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 12.779

View more
  60 in total

1.  Distinct phases of human prostate cancer initiation and progression can be driven by different cell-types.

Authors:  Tanya Stoyanova; Andrew S Goldstein
Journal:  Cancer Cell Microenviron       Date:  2014

2.  CD66+ cells in cervical precancers are partially differentiated progenitors with neoplastic traits.

Authors:  Chitra Pattabiraman; Shiyuan Hong; Vignesh K Gunasekharan; Annapurna Pranatharthi; Jeevisha Bajaj; Sweta Srivastava; H Krishnamurthy; Aswathy Ammothumkandy; Venkat G Giri; Laimonis A Laimins; Sudhir Krishna
Journal:  Cancer Res       Date:  2014-09-29       Impact factor: 12.701

3.  Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade.

Authors:  Brijesh Kumar; Mayuri Prasad; Poornima Bhat-Nakshatri; Manjushree Anjanappa; Maitri Kalra; Natascia Marino; Anna Maria Storniolo; Xi Rao; Sheng Liu; Jun Wan; Yunlong Liu; Harikrishna Nakshatri
Journal:  Cancer Res       Date:  2018-07-11       Impact factor: 12.701

Review 4.  Human cancer growth and therapy in immunodeficient mouse models.

Authors:  Leonard D Shultz; Neal Goodwin; Fumihiko Ishikawa; Vishnu Hosur; Bonnie L Lyons; Dale L Greiner
Journal:  Cold Spring Harb Protoc       Date:  2014-07-01

Review 5.  Role of p75 neurotrophin receptor in stem cell biology: more than just a marker.

Authors:  Elisa Tomellini; Chann Lagadec; Renata Polakowska; Xuefen Le Bourhis
Journal:  Cell Mol Life Sci       Date:  2014-01-31       Impact factor: 9.261

6.  Of plasticity and specificity: dialectics of the micro- and macro-environment and the organ phenotype.

Authors:  Ramray Bhat; Mina J Bissell
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2014

7.  Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells.

Authors:  Tanya Stoyanova; Aaron R Cooper; Justin M Drake; Xian Liu; Andrew J Armstrong; Kenneth J Pienta; Hong Zhang; Donald B Kohn; Jiaoti Huang; Owen N Witte; Andrew S Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

8.  Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial-mesenchymal transition and mammary cancer stem cell activities in vivo.

Authors:  Huaping Fan; Xiaofeng Zhao; Shaogang Sun; Ming Luo; Jun-Lin Guan
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

9.  Breast Cancer Cell Detection and Characterization from Breast Milk-Derived Cells.

Authors:  Poornima Bhat-Nakshatri; Brijesh Kumar; Ed Simpson; Kandice K Ludwig; Mary L Cox; Hongyu Gao; Yunlong Liu; Harikrishna Nakshatri
Journal:  Cancer Res       Date:  2020-09-15       Impact factor: 12.701

Review 10.  Prostate Luminal Progenitor Cells in Development and Cancer.

Authors:  Dingxiao Zhang; Shuhong Zhao; Xinyun Li; Jason S Kirk; Dean G Tang
Journal:  Trends Cancer       Date:  2018-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.